HDAC3 and acute myeloid leukemia: To examine whether the immunophenotype of ERG-dependent AML cells alters upon HDAC3 inhibition, flow cytometry analysis was conducted 96 h following treatment with RGFP966 on SKNO1, TF1, and ELF-153.